Quarterly report pursuant to Section 13 or 15(d)

4. Stock Option Plan (Details Narrative)

v3.20.2
4. Stock Option Plan (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Dec. 31, 2019
Dividends     0.00%    
Stock options granted 7,000 0 174,357 [1] 0 0
Weighted average grant date fair value $ 3.87   $ 9.05    
Fair value of shares vested $ 300,000 $ 200,000 $ 900,000 $ 600,000  
Aggregate intrinsic value of outstanding stock options 3,000,000   3,000,000    
Unamortized unvested balance of stock base compensation 2,100,000   $ 2,100,000    
Unamortized unvested balance of stock base compensation, period     2 years 8 months 1 day    
Minimum          
Expected term     5 years 3 months 18 days    
Volatility     55.00%    
Risk free interest rate     0.40%    
Maximum          
Expected term     6 years 1 month 6 days    
Volatility     85.00%    
Risk free interest rate     2.90%    
General and Administrative Expenses          
Employee and non-employee director stock-based compensation expense 163,807 154,906 $ 633,462 470,232  
Research and Development Expenses          
Employee and non-employee director stock-based compensation expense 102,346 67,347 303,415 202,012  
Stock-based compensation expense for non-employees $ 17,560 $ 20,704 $ 52,691 $ 62,121  
[1] 174,357 options vest as follows: options to purchase 145,648 shares of the Company's common stock vest 6/48ths on the six-month anniversary of grant date and 1/48th per month thereafter; options to purchase 22,584 shares of the Company's common stock vest quarterly over one year; and options to purchase 6,125 shares of the Company's common stock vest monthly over one year. Exercise prices are noted in the paragraphs above this table.